GenCell: The Barclays Loan, the June 2027 Deferral, and What Actually Bought the Company Time
The move to June 30, 2027 bought GenCell time, but it did not change the loan's core economics: prime plus 0.5% interest, collateral on the charging station, and a conversion trigger that still depends on a new equity raise. The gap between the 2025 statements and the shareholder economics investors must read in 2026 is still being bridged through notes and follow-on disclosures, not through a clean reported picture.
One Counterparty, Three Roles
The main article argued that the Barclays layer is no longer a side financing detail. It now sits at the center of the new GenCell thesis. This follow-up isolates the loan itself, why the June 2027 deferral matters, and why it still falls well short of a solution.
The first non-obvious point is that Barclays sits here in three roles at once. It is the party that injected NIS 30 million in the control transaction, the party that extended the loan that funded the deal gap, and the party from which the company leases the Ein Bokek site on which the charging station operates. In other words, what bought GenCell time was not external bank refinancing layered over the business. It was a related-party structure built around the same asset.
That structure became visible on November 12, 2025, when Barclays exercised the PUT option on the charging station. The consideration was set at NIS 75.679 million, plus VAT of NIS 13.622 million. Of that amount, NIS 30 million was offset against the equity investment leg, and the remainder, NIS 45.679 million plus the VAT component, together NIS 59.3 million, was paid by way of a loan extended by Barclays to the company. On February 2, 2026 the company paid back the VAT component of NIS 13.622 million. Put differently, the equity did not cover the transaction. The debt closed the gap.
The site layer matters as much as the money layer. The company leases about 616 square meters in Ein Bokek from Barclays for 24 years and 11 months in order to operate the charging station with 32 charging points and 40 dedicated parking spaces. The nominal rent is one shekel per month, but the report also says the real economics of using the leased site were already embedded in the total consideration of the transaction as capitalized rent for about 25 years. So even the access layer to the asset is not outside the Barclays transaction. It is part of it.
What Was Deferred, and What Stayed Exactly the Same
On December 7, 2025 the audit committee approved the market terms of the loan. Interest was set at prime plus 0.5%, repayment was set at NIS 6 million per year, principal and interest together, paid twice a year, and the company received a prepayment right with no fee if it could find better financing elsewhere. The collateral was the charging station itself, and the report adds that as of the report date the pledges had not yet been registered, although the parties intended to register them.
The March 2026 update changed one thing only. It pushed the first payment date from June 30, 2026 to June 30, 2027. Note 1 further clarifies that the deferred first payment will amount to NIS 3 million. Every other loan term, including the interest rate, the prepayment right, and the collateral package, remained unchanged.
| Item | Before the March 2026 update | After the update | What it means |
|---|---|---|---|
| First payment date | June 30, 2026 | June 30, 2027 | The company received a timing delay, not debt forgiveness |
| Interest | Prime plus 0.5% | Unchanged | The price of money did not improve |
| Repayment cadence | NIS 6 million per year, in two payments | Unchanged | The deferral did not change the pace of repayment once it starts |
| Prepayment | Allowed without fee if better financing is found | Unchanged | The company still needs an outside financing market to improve terms |
| Collateral | Pledge of the charging station | Unchanged | The financing layer still sits directly on the key operating asset |
This was not an operating extension created by the station itself. It was a one-year postponement of the first cash test, while the cost of debt and the collateral stayed in place.
The Conversion Test Arrives Before the Cash Test
The January 13, 2026 shareholders' meeting also approved a debt-to-equity conversion mechanism, but the terms matter. The conversion is not an automatic company right to erase the loan when convenient. It is conditioned on the company raising, within 12 months of the meeting approval, new equity from the public or from institutional investors in an amount equal to the Barclays loan or more. Only then would the full Barclays loan convert into shares at the same effective share price as the new raise.
That detail is critical because the conversion window should expire in January 2027, while the new first payment date was deferred to June 30, 2027. So the capital-markets test arrives before the first scheduled cash payment. If the company cannot secure a sufficiently large outside raise by then, the conversion mechanism does not automatically become a safety cushion when repayment starts.
For minority shareholders, that means conversion is not free upside. If it happens, it comes together with a new share issuance at the same effective price. If it does not happen, the debt remains debt, and the charging station remains the pledged asset beneath it.
The 2025 Statements Still Stop Short of the 2026 Shareholder Economics
This is where the accounting gap becomes most important. Note 1 says explicitly that the company will reflect the share issuance, the Barclays investment, and the charging-station acquisition in the 2026 financial statements. That means the audited 2025 package still ends just before the new shareholder economics are presented in a clean reported form.
The audited year-end 2025 picture remained difficult: a total loss of about USD 18.906 million, negative operating cash flow of about USD 8.999 million, working capital of about USD 3.566 million, and cash of about USD 4.8 million, of which USD 621 thousand was restricted. On top of that, the company's own 15 to 18 month liquidity view rests on several assumptions, including that Barclays repayment will start only on June 30, 2027, that no inventory build will be required, that orders will be realized and collected, that a credit in the counterclaim will be received, and that about NIS 1 million will still be needed to complete the service elements around the station.
| Liquidity assumption disclosed in Note 1 | Why it matters for shareholders |
|---|---|
| Barclays repayment starts only on June 30, 2027 | The deferral is part of the liquidity case, not a side technicality |
| No inventory build | Any renewed working-capital demand could shorten the runway |
| Orders are realized and collected | The liquidity view depends on collections, not only on sales |
| A credit in the counterclaim is received | Part of the flexibility comes from a non-operating item |
| About NIS 1 million is still needed for the station's service layer | Even after the transaction, more cash is needed to bring the site into a fuller commercial state |
That is why what was bought here is not certainty, but conditional time. The same note says the company depends on one income-generating asset, faces uncertainty around demand and around the ability to raise new capital, and describes the charging station as operating but not yet open to the general public at the report date. That matters because the same station is both the center of the new operating thesis and the collateral for the loan.
Conclusion, This Is a New Calendar, Not a New Balance Sheet
The Barclays loan did not solve GenCell. It did three things at once: it turned the gap between the NIS 30 million equity leg and the charging-station valuation into controller financing, it delayed the first payment test by a year, and it left almost every other debt term essentially unchanged.
The practical takeaway for shareholders is simpler than it first appears. What bought the company time was not proven cash generation from the site, not yet a commercial engine that has already validated itself, and not an automatic debt-to-equity escape hatch. What bought time was the combination of a related-party loan, a delayed amortization start, and the assumption that the company can get through the coming months before cash repayment actually begins.
Until the 2026 statements present the charging station, the debt, and their relationship in a full reported form, investors are still reading an in-between phase. The new asset is already at the center of the story, but its shareholder economics still run through notes, loan terms, and deferrals, not through a clean reported layer of earnings and cash flow that has already been proven.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.